penicillamine has been researched along with thromboxane a2 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunnane, SC; Horrobin, DF; Manku, MS | 1 |
Barradas, MA; Dandona, P; Epstein, O; Fonseca, V; Hutton, RA; Jeremy, JY; McIntyre, N; Mikhailidis, DP | 1 |
De la Lande, IS; Horowitz, JD; Stafford, I; Zhang, CL | 1 |
Craven, PA; DeRubertis, FR; Studer, RK | 1 |
De la Lande, IS; Horowitz, JD; Stafford, I | 1 |
Champion, HC; Kadowitz, PJ | 1 |
Afzal, MN; Saeed, SA; Shah, BH | 1 |
Duszyk, M; Jurasz, P; Mayers, I; Miranda, C; Radomski, MW; Sawicka, J; Sawicki, G | 1 |
8 other study(ies) available for penicillamine and thromboxane a2
Article | Year |
---|---|
The pineal and regulation of fibrosis: pinealectomy as a model of primary biliary cirrhosis: roles of melatonin and prostaglandins in fibrosis and regulation of T lymphocytes.
Topics: Animals; Colchicine; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Melatonin; Models, Biological; Penicillamine; Pineal Gland; Prostaglandins E; Schizophrenia; T-Lymphocytes; Thromboxane A2; Thromboxanes; Zinc | 1979 |
Platelet aggregation and thromboxane A2 release in primary biliary cirrhosis and effect of D-penicillamine treatment.
Topics: Aged; Cholesterol; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Penicillamine; Platelet Aggregation; Platelet Count; Thromboxane A2; Thromboxane B2 | 1988 |
S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Captopril; Cattle; Coronary Vessels; Dose-Response Relationship, Drug; Drug Tolerance; In Vitro Techniques; Nitroglycerin; Nitroso Compounds; Penicillamine; Prostaglandin Endoperoxides, Synthetic; S-Nitroso-N-Acetylpenicillamine; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1994 |
Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor beta, and fibronectin synthesis induced by thromboxane.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cells, Cultured; Cyclic GMP; Depression, Chemical; Enzyme Activation; Extracellular Matrix Proteins; Female; Fibronectins; Gene Expression Regulation; Glomerular Mesangium; Models, Biological; Nitric Oxide; Penicillamine; Phosphorylation; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Thionucleotides; Thromboxane A2; Thromboxanes; Transforming Growth Factor beta | 1996 |
Heterogeneity of glyceryl trinitrate response in isolated bovine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Cattle; Coronary Vessels; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Penicillamine; Prostaglandin Endoperoxides, Synthetic; S-Nitroso-N-Acetylpenicillamine; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents | 1997 |
Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
Topics: Blood Platelets; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Humans; Nitric Oxide Donors; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Verapamil | 1998 |
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Topics: Adenosine Diphosphate; Blood Platelets; Cell Communication; Enzyme Inhibitors; Epoprostenol; Fibrosarcoma; Gelatinases; Glutathione; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Penicillamine; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Thromboxane A2; Tumor Cells, Cultured | 2001 |